Once there is evidence of systemic involvement in malignant melanoma, treat
ment options become severely limited and the disease is virtually incurable
. There are,however, options available to treat patients, including single-
agent chemotherapy, single-agent biologic response modifier (BRM), combinat
ion chemotherapy, and the combination of chemotherapeutic agents and BRMs.
These treatment modalities and their indications for use are discussed.